"Designing Growth Strategies is in our DNA"

Endoscope Reprocessing Market Size, Share, and Industry Analysis, By Product (High-Level Disinfectants & Test Strips, Detergents & Enzymatic Wipes, Automated Endoscope Reprocessors {Single basin and Double basin}, and Others), By Endoscope Type (Flexible and Rigid), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast till 2034

Last Updated: September 21, 2026 | Format: PDF | Report ID: FBI116519

 

Endoscope Reprocessing Market Overview

The endoscope reprocessing market size was valued at USD 2.71 billion in 2025 and is expected to reach a market valuation of USD 2.98 billion in 2026. Furthermore, the market is projected to reach a market valuation of USD 6.45 billion by 2034, exhibiting a CAGR of 10.1% during the forecast period.

Currently, the healthcare authorities and accreditation bodies globally are tightening protocols for endoscope reprocessing to reduce healthcare-associated infections (HAIs). Facilities are under pressure to adopt validated processes, digital tracking, and automation to comply with evolving standards such as ANSI/AAMI ST91. This is expected to support the adoption of endoscope reprocessing solutions, driving the market growth.

Endoscope Reprocessing Market Driver

Rising Endoscopic Procedure Volumes to Drive Market Growth

In recent years, there has been a surge in demand for endoscopic diagnosis and treatment due to the growing incidence of conditions, such as gastrointestinal issues, respiratory diseases, and various types of cancer. This is boosting demand for endoscopes and the need for effective reprocessing solutions, such as automated endoscope reprocessors (AERs) and related products, which is anticipated to drive market growth.

  • For instance, the NCBI data from May 2024 shows that the U.S. conducts over 17.7 million gastrointestinal (GI) endoscopic procedures each year.

Download Free sample to learn more about this report.

According to data published by the Olympus Corporation, Thailand had around 31 endoscopists per million people as of September 2023.

Endoscope Reprocessing Market Restraint

High Cost of Equipment & Consumables to Hamper the Market Growth

Automated endoscope reprocessors (AERs), advanced detergents, liquid chemical sterilizers, and tracking systems require significant capital and ongoing expenses, which may lead smaller hospitals and clinics to rely on manual methods, deterring them from purchasing such products. This is anticipated to slow down the market growth over the forecast period.

Endoscope Reprocessing Market Opportunity

Emerging Markets and Growing Investments to Offer Lucrative Growth Opportunities

In recent years, several hospitals in emerging regions have expanded their surgical procedures and diagnostic capacities, creating significant opportunities for the use of safe & efficient endoscope reprocessing solutions, especially across the Asia Pacific, Latin America, and the Middle East & Africa.

  • For instance, in April 2025, Yashoda Hospitals inaugurated a Center of Excellence for Robotic Neurosurgery and Neuro Endoscopy in Secunderabad, India.

Segmentation

By Product

By Endoscope Type

By End-user

By Region

  • High-Level Disinfectants & Test Strips
  • Detergents & Enzymatic Wipes
  • Automated Endoscope Reprocessors

o    Single basin

o    Double basin

  • Others
  • Flexible
  • Rigid
  • Hospitals & ASCs
  • Specialty Clinics
  • Others

·      North America (U.S. and Canada)

·      Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

·      Latin America (Brazil, Mexico, and the Rest of Latin America)

·      Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Number of Endoscopic Procedures - by Key Countries/Sub-regions,
  • Advancements in Endoscope Reprocessing Equipment
  • Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Product

In terms of product, the market is segmented into high-level disinfectants & test strips, detergents & enzymatic wipes, automated endoscope reprocessors, and others. The automated endoscope reprocessors are further sub-segmented into single basin and double basin.

The high-level disinfectants & test strips segment is expected to hold the major share of the global market during the forecast period. The growth is attributed to their mandatory use in every reprocessing cycle, recurring consumption linked to procedure volumes, strict regulations, and broad adoption across all healthcare settings.

Analysis by Endoscope Type

Based on endoscope type, the market is divided into flexible and rigid.

The flexible segment is expected to hold the largest share of the global market during the forecast period. The segment’s growth is attributed to widespread usage of flexible endoscopes in gastroenterology, pulmonoscopy, and urology procedures performed daily across hospitals& ASCs, and specialty clinics. Moreover, a surge in such procedures is anticipated to drive the segment’s growth.

  • For instance, according to the data from the AME Journal in December 2024, around 500,000 bronchoscopic procedures are performed annually in the U.S.

Analysis by End-user

Based on end-user, the market is divided into hospitals & ASCs, specialty clinics, and others.

The hospital & ASCs segment is expected to hold the largest share of the global market during the forecast period. Hospitals & ASCs perform the majority of gastrointestinal, pulmonary, urology, and surgical endoscopic procedures, resulting in the highest volume of scopes requiring reprocessing. This is anticipated to drive the segment’s growth.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 40.5% share of the global endoscope reprocessing market in 2025. The region's growth is attributed to standard regulations from the FDA, CDC, and The Joint Commission that require healthcare facilities to adopt validated, automated, and well-documented reprocessing workflows.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The region’s growth is attributed to the rapid expansion of healthcare infrastructure in China, India, and Southeast Asia, which is favoring the adoption of endoscope reprocessing solutions. Moreover, the adoption of these solutions is also driven by increasing volumes of diagnostic endoscopic procedures due to an aging population.

  • For instance, in January 2025, Dr. Ksheetij Kothari mentioned that approximately 1.2 million people undergo colonoscopies each year in India.

Key Players Covered

The global endoscope reprocessing market is fragmented, with key players offering products from manual cleaning detergents and disinfectants to automated reprocessors.

The report includes the profiles of the following key players:

  • STERIS (Ireland)
  • Getinge (Sweden)
  • ASP (U.S.)
  • Olympus Corporation (Japan)
  • Ecolab (U.S.)
  • PENTAX Medical (Japan)
  • Steelco S.p.A. (Italy)
  • Belimed (Switzerland)
  • Wassenburg Medical B.V. (Netherlands)
  • Weigert (Germany)

Key Industry Developments

  • September 2024: Olympus Corporation launched Sapphire, Australia's first flexible endoscope sterilization facility in Melbourne, to deliver sterilization services for clinical facilities.
  • August 2023: Olympus Corporation introduced ETD Basic and ETD Premium systems for automated reprocessing of flexible endoscopes.


  • 2021-2034
  • 2025
  • 2021-2024
  • 100
  • Special Price

    (Offer valid till 15th Oct 2026)

Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann